Healthcare provider profile · identity verified

Sirisha Thumu

Family Practice · BROOKLYN, NY · NPI 1225471097

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	466	168
Levothyroxine Sodium	Levothyroxine Sodium	384	124
Lisinopril	Lisinopril	354	114
Losartan Potassium	Losartan Potassium	337	121
Amlodipine Besylate	Amlodipine Besylate	261	104
Albuterol Sulfate Hfa	Albuterol Sulfate	228	128
Fluticasone Propionate	Fluticasone Propionate	173	74
Meloxicam	Meloxicam	163	69
Hydrochlorothiazide	Hydrochlorothiazide	157	61
Paxlovid	Nirmatrelvir/Ritonavir	157	157
Trazodone Hcl	Trazodone Hcl	146	49
Metformin Hcl Er	Metformin Hcl	143	50
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	135	36
Pantoprazole Sodium	Pantoprazole Sodium	135	59
Omeprazole	Omeprazole	129	40
Atenolol	Atenolol	125	40
Metoprolol Succinate	Metoprolol Succinate	125	48
Fluoxetine Hcl	Fluoxetine Hcl	121	34
Metoprolol Tartrate	Metoprolol Tartrate	121	42
Furosemide	Furosemide	120	51
Gabapentin	Gabapentin	115	39
Simvastatin	Simvastatin	114	42
Famotidine	Famotidine	111	40
Cefadroxil	Cefadroxil	110	103
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	108	37
Alendronate Sodium	Alendronate Sodium	103	41
Duloxetine Hcl	Duloxetine Hcl	90	45
Potassium Chloride	Potassium Chloride	89	34
Quetiapine Fumarate	Quetiapine Fumarate	83	18
Hydralazine Hcl	Hydralazine Hcl	77	27
Hydrocortisone	Hydrocortisone	77	41
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	74	65
Alvesco	Ciclesonide	72	32
Citalopram Hbr	Citalopram Hydrobromide	68	23
Ibuprofen	Ibuprofen	68	37
Ipratropium Bromide	Ipratropium Bromide	68	37
Tamsulosin Hcl	Tamsulosin Hcl	68	25
Sertraline Hcl	Sertraline Hcl	67	28
Prednisone	Prednisone	66	60
Doxycycline Monohydrate	Doxycycline Monohydrate	64	61
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	64	27
Venlafaxine Hcl Er	Venlafaxine Hcl	61	18
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	58	55
Triamcinolone Acetonide	Triamcinolone Acetonide	57	38
Glipizide Er	Glipizide	55	19
Metformin Hcl	Metformin Hcl	54	20
Rosuvastatin Calcium	Rosuvastatin Calcium	52	22
Terazosin Hcl	Terazosin Hcl	48	16
Carvedilol	Carvedilol	45	13
Sumatriptan Succinate	Sumatriptan Succinate	45	suppressed
Clopidogrel	Clopidogrel Bisulfate	44	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	44	14
Eliquis	Apixaban	44	15
Lovastatin	Lovastatin	44	17
Spiriva Respimat	Tiotropium Bromide	44	16
Nabumetone	Nabumetone	42	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	39
Tizanidine Hcl	Tizanidine Hcl	42	27
Trospium Chloride	Trospium Chloride	42	suppressed
Allopurinol	Allopurinol	40	18
Hydroxyzine Hcl	Hydroxyzine Hcl	40	16
Tramadol Hcl	Tramadol Hcl	40	23
Montelukast Sodium	Montelukast Sodium	39	16
Glipizide	Glipizide	36	14
Pradaxa	Dabigatran Etexilate Mesylate	36	suppressed
Estradiol	Estradiol	35	17
Ondansetron Hcl	Ondansetron Hcl	34	27
Rizatriptan	Rizatriptan Benzoate	32	suppressed
Warfarin Sodium	Warfarin Sodium	32	13
Memantine Hcl	Memantine Hcl	31	suppressed
Spironolactone	Spironolactone	31	12
Acyclovir	Acyclovir	30	15
Oxycodone Hcl	Oxycodone Hcl	30	11
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	30	11
Clobetasol Propionate	Clobetasol Propionate	29	18
Wixela Inhub	Fluticasone Propion/Salmeterol	29	suppressed
Breyna	Budesonide/Formoterol Fumarate	27	13
Nortriptyline Hcl	Nortriptyline Hcl	27	11
Baclofen	Baclofen	26	11
Colchicine	Colchicine	26	suppressed
Xarelto	Rivaroxaban	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Propranolol Hcl	Propranolol Hcl	24	11
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Alprazolam	Alprazolam	23	suppressed
Lorazepam	Lorazepam	23	12
Mirtazapine	Mirtazapine	23	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	23	13
Lidocaine	Lidocaine	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amoxicillin	Amoxicillin	21	17
Fluocinonide	Fluocinonide	21	13
Metronidazole	Metronidazole	21	15
Nystatin	Nystatin	21	12
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	20	20
Azelastine Hcl	Azelastine Hcl	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	15
Nitroglycerin	Nitroglycerin	18	suppressed
Pravastatin Sodium	Pravastatin Sodium	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	17	17
Erythromycin	Erythromycin Base	17	15
Lamotrigine	Lamotrigine	17	suppressed
Torsemide	Torsemide	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Fluconazole	Fluconazole	15	13
Pregabalin	Pregabalin	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Cephalexin	Cephalexin	13	13
Ciclopirox	Ciclopirox	13	suppressed
Donepezil Hcl	Donepezil Hcl	13	suppressed
Valsartan	Valsartan	13	suppressed
Verapamil Er	Verapamil Hcl	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Cholestyramine	Cholestyramine (With Sugar)	12	suppressed
Cyclosporine	Cyclosporine	12	suppressed
Divalproex Sodium	Divalproex Sodium	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Temazepam	Temazepam	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Finasteride	Finasteride	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Tadalafil	Tadalafil	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error